New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 16, 2013
04:55 EDTDXCM, DXCM, DXCM, EW, EW, EW, AGN, AGN, AGN, MASI, MASI, MASI, ELGX, ELGX, ELGX, ATEC, ATEC, ATEC, ONVO, ONVO, ONVO, SQNM, SQNM, SQNM, NUVA, NUVA, NUVA, RMD, RMD, RMDBTIG to host a bus tour
Inaugural Southern California Medical Tech Bus Tour travels throughout San Diego and Irvine, California visiting with various companies on December 16-18.
News For DXCM;NUVA;SQNM;ONVO;ATEC;ELGX;MASI;AGN;EW;RMD From The Last 14 Days
Check below for free stories on DXCM;NUVA;SQNM;ONVO;ATEC;ELGX;MASI;AGN;EW;RMD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 14, 2014
10:00 EDTEWEdwards Lifesciences rises 13.9%
Subscribe for More Information
09:00 EDTEWEdwards Lifesciences rises 11.3%
Edwards Lifesciences is up 11.3%, or $8.28, to $81.25
08:59 EDTEWOn The Fly: Pre-market Movers
Subscribe for More Information
08:12 EDTEWEdwards Lifesciences price target raised to $90-$91 from $82-$83 at Wells Fargo
Wells Fargo increased its price target on Edwards after a federal court granted a preliminary injunction limiting the sale of a competing product, Medtronic's (MDT) CoreValve. The firm said the injunction was a "major surprise," and estimates that the injunction could increase Edwards EPS by 15c in 2014 and 34c in 2015. Wells keeps an Outperform rating on the stock.
07:39 EDTEWEdwards Lifesciences upgraded to Buy from Fair Value at CRT Capital
Subscribe for More Information
06:22 EDTEWMedtronic downgraded to Neutral from Overweight at JPMorgan
Subscribe for More Information
06:21 EDTEWEdwards Lifesciences upgraded to Neutral from Underweight at JPMorgan
Subscribe for More Information
April 13, 2014
15:10 EDTEWMedtronic says CoreValve ruling has no impact outside U.S.
Subscribe for More Information
April 12, 2014
19:50 EDTEWEdwards says court limits sale of Medtronic CoreValve system in U.S.
Edwards Lifesciences (EW) announced that the U.S. District Court for the District of Delaware granted a preliminary injunction limiting the sale of Medtronic's (MDT) CoreValve system in the United States. The court ordered the injunction to go into effect in seven business days. The hearing related to a federal jury decision in 2010 that CoreValve willfully infringes Edwards' U.S. Andersen transcatheter aortic valve replacement patent. At the conclusion of the hearing, Chief Judge Gregory Sleet ordered Edwards and Medtronic to confer on what instances the CoreValve device could continue to be used in the treatment of U.S. patients at centers currently trained on CoreValve. There is a large body of evidence demonstrating the safety and performance of the Edwards SAPIEN valves, and the company remains committed to ensuring patients have appropriate access to transcatheter therapy. This case was initiated by Edwards in 2008. On April 1, 2010, a federal jury found Medtronic willfully infringed Edwards' U.S. Andersen patent and awarded damages. In Nov. 2012, the U.S. Court of Appeals for the Federal Circuit affirmed the jury decision; in Oct. 2013, the U.S. Supreme Court declined to hear Medtronic's appeal. The patent involved in this suit is part of the Andersen family of patents. The U.S. Andersen patent was issued in 1995. A petition has been filed with the U.S. Patent and Trademark Office to extend this patent into early 2016. In a separate case, a federal jury in January found that Medtronic CoreValve had willfully infringed Edwards' U.S. Cribier transcatheter heart valve patent, and awarded damages to Edwards in that trial.
April 11, 2014
18:44 EDTAGNJ&J halting development of Botox competitor, WSJ says
Subscribe for More Information
April 10, 2014
10:00 EDTDXCMOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:50 EDTDXCMDexCom upgraded at Sterne Agee
As noted earlier, Sterne Agee upgraded DexCom to Buy from Neutral. The firm expects the company to generate strong annual revenue growth, and believes that use of its G4 Platinum product will become more widespread after the FDA approved it for people ages 2-17. Target $50.
08:46 EDTONVOOrganovo says technology successfully fabricated 3D breast tissues in study
Subscribe for More Information
05:54 EDTDXCMDexCom upgraded to Buy from Neutral at Sterne Agee
Price target is $50.
April 9, 2014
08:24 EDTELGXPiper Jaffray's medtech analysts hold an analyst/industry conference call
The MedTech Analyst Team focuses on Piper Jaffray's covered universe from the perspective of Technical Analyst Johnson ahead of 1Q14 earnings results on an Analyst/Industry conference call to be held on April 11 at 10 am.
April 8, 2014
10:53 EDTONVOSimeon Research reiterates $1.35 price target for Organovo shares
Reference Link
07:26 EDTEWElsevier Business Intelligence to hold a conference
Subscribe for More Information
07:22 EDTSQNMCaSA-ISPE to hold a conference
21st Annual Lilfe Sciences Technology Conference is being held in Raleigh, North Carolina on April 8.
April 7, 2014
08:31 EDTMASIMasimo PVI helps clinicians optimize fluid administration
Subscribe for More Information
April 4, 2014
05:14 EDTEWEdwards Lifesciences INTUITY Elite valve system receives CE Mark
Edwards Lifesciences announced it has received CE Mark for the advanced EDWARDS INTUITY Elite valve system. This next-generation, rapid deployment system facilitates smaller incisions in surgical aortic valve replacement, or AVR, procedures, and is built upon extensive evidence supporting the durability of the Carpentier-Edwards PERIMOUNT heart valve design.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use